Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
A device for measuring an analyte concentration level in a subject. The device includes: a light source configured for illuminating at least a portion of an anterior region of an eye of the subject with incident light having a substantially broad illumination spectrum at an angle substantially tangential to the surface of the eye; an optical collector configured for detecting reflected light from the at least a portion of the anterior region of the eye; an analyzer configured for analyzing the detected reflected light; and a processor configured to determine the analyte concentration level in the subject based on the analyzed reflected light.
Core Innovation
The invention provides a non-invasive device and method for measuring an analyte concentration level in a subject by illuminating at least a portion of an anterior region of an eye. The illumination uses incident light that is incoherent and has a substantially broad illumination spectrum while being applied at an angle substantially tangential to the surface of the eye. Scattered or reflected light from the illuminated anterior region is collected for analysis.
The collected scattered or reflected light is detected and processed to determine an analyte concentration level. The analysis is based on comparing a detected characteristic spectrum to reference characteristic spectra associated with analyte concentration in the anterior region of a healthy eye. In embodiments, a modulator is used to modulate incident light to reduce extraneous effects, and optical filters may be used to reduce ambient light and intrinsic fluorescence effects.
The disclosure further describes embodiments in which analyte determination is correlated with health condition indicators and hydration-related states. In particular, correlation is described between measured analyte concentration level and hydration/osmolality associated with sodium based salts, including natremia. Additional embodiments describe optical density and wavelength-dependent optical absorption related to proteins and cells, including use for assessing blood-aqueous barrier disruption and glycemic condition, and a split-beam polarization analysis approach for optically active analytes such as glucose.
Claims Coverage
The provided independent claims are clm-00001 (device) and clm-00013 (method). Across these claims, the core inventive features include tangential illumination of an anterior eye region using incoherent, substantially broad illumination, detecting scattered or reflected light, and determining analyte concentration using reference data from a healthy eye.
Tangential incoherent broad-spectrum illumination of an anterior eye region
Illuminating at least a portion of an anterior region of an eye of the subject with incident light having a substantially broad illumination spectrum at an angle substantially tangential to the surface of the eye.
Detecting scattered or reflected light from the anterior eye region
Detecting at least one of scattered or reflected light from the at least a portion of the anterior region of the eye.
Determining health condition using reference data from a healthy eye
Determining a subject’s health condition from an analyte concentration level using reference data that represents analyte concentration in the anterior region of a healthy eye.
Overall claim coverage centers on non-invasive ocular analyte measurement using incoherent, substantially broad-spectrum illumination applied tangentially to the eye surface and detection of scattered or reflected light from the anterior region, with dependent embodiments extending the approach to modulation for reduction of extraneous effects and to health-condition determination using reference data from a healthy eye.
Stated Advantages
Non-invasive ocular monitoring for measuring an analyte concentration level in a subject.
Reduced extraneous effects through modulating incident light.
Reduced ambient light and intrinsic fluorescence effects through optical filters.
Enables correlation of measured analyte concentration level with hydration/osmolality and with indicators such as blood-aqueous barrier disruption and glycemic condition.
Documented Applications
Assessing blood-aqueous barrier disruption.
Assessing glycemic condition.
Integration with eyewear or head-mounted implementations.
Interested in licensing this patent?